353 related articles for article (PubMed ID: 17634958)
1. Molecular genetic evidence supporting the neoplastic nature of stromal cells in 'fibrosis' after chemotherapy for testicular germ cell tumours.
Cheng L; Zhang S; Wang M; Davidson DD; Morton MJ; Huang J; Zheng S; Jones TD; Beck SD; Foster RS
J Pathol; 2007 Sep; 213(1):65-71. PubMed ID: 17634958
[TBL] [Abstract][Full Text] [Related]
2. Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumors is derived from the same progenitor cells as the teratoma.
Brandli DW; Ulbright TM; Foster RS; Cummings OW; Zhang S; Sweeney CJ; Eble JN; Cheng L
Cancer Res; 2003 Sep; 63(18):6063-8. PubMed ID: 14522936
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
4. Clonal evidence for the progression of a testicular germ cell tumor to angiosarcoma.
Idrees MT; Kuhar M; Ulbright TM; Zhang S; Agaram N; Wang M; Grignon DJ; Eble JN; Cheng L
Hum Pathol; 2010 Jan; 41(1):139-44. PubMed ID: 19836053
[TBL] [Abstract][Full Text] [Related]
5. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
Brown JA; Bihrle R; Foster RS
Urology; 2008 May; 71(5):911-4. PubMed ID: 18342916
[TBL] [Abstract][Full Text] [Related]
6. Retroperitoneal lymph node dissection after chemotherapy for germ cell tumours: is a full bilateral template always necessary?
Steiner H; Peschel R; Bartsch G
BJU Int; 2008 Aug; 102(3):310-4. PubMed ID: 18325053
[TBL] [Abstract][Full Text] [Related]
7. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
Kuczyk MA; Bokemeyer C; Serth J; Machtens S; Höfner K; Jonas U
Urologe A; 1996 Jan; 35(1):35-45. PubMed ID: 8851847
[TBL] [Abstract][Full Text] [Related]
8. Clonal origin of metastatic testicular teratomas.
Jones TD; Wang M; Sung MT; Zhang S; Ulbright TM; Eble JN; Beck SD; Foster RS; Anagnostou JJ; Conner C; Cheng L
Clin Cancer Res; 2006 Sep; 12(18):5377-83. PubMed ID: 16982812
[TBL] [Abstract][Full Text] [Related]
9. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
[TBL] [Abstract][Full Text] [Related]
10. Retroperitoneal lymph node dissection after chemotherapy.
Winter C; Raman JD; Sheinfeld J; Albers P
BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
[TBL] [Abstract][Full Text] [Related]
11. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection.
Ehrlich Y; Yossepowitch O; Kedar D; Baniel J
BJU Int; 2006 Jun; 97(6):1221-4. PubMed ID: 16686715
[TBL] [Abstract][Full Text] [Related]
12. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
[TBL] [Abstract][Full Text] [Related]
13. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
Eggener SE; Carver BS; Loeb S; Kondagunta GV; Bosl GJ; Sheinfeld J
Cancer; 2007 Feb; 109(3):528-35. PubMed ID: 17177200
[TBL] [Abstract][Full Text] [Related]
14. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic evidence supporting the origin of somatic-type malignancy and teratoma from the same progenitor cell.
Kum JB; Ulbright TM; Williamson SR; Wang M; Zhang S; Foster RS; Grignon DJ; Eble JN; Beck SD; Cheng L
Am J Surg Pathol; 2012 Dec; 36(12):1849-56. PubMed ID: 23154771
[TBL] [Abstract][Full Text] [Related]
16. Nonseminomatous germ cell tumor after chemotherapy with residual mass invading the spine.
Berglund RK; Lyden SP; Tsai EC; Lieberman I; Klein EA
Eur Urol; 2006 Aug; 50(2):372-4. PubMed ID: 16626860
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
[TBL] [Abstract][Full Text] [Related]
18. Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model.
Faulkner SW; Leigh DA; Oosterhuis JW; Roelofs H; Looijenga LH; Friedlander ML
Br J Cancer; 2000 Sep; 83(6):729-36. PubMed ID: 10952776
[TBL] [Abstract][Full Text] [Related]
19. [Exeresis of residual masses of germinal tumors of the testis after chemotherapy].
Bassoulet J; du Chatelard P; Auberget JL; Merrer J; Guillemot MC; Timbal Y
Ann Urol (Paris); 1989; 23(5):388-92. PubMed ID: 2560360
[TBL] [Abstract][Full Text] [Related]
20. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
Stephenson AJ; Bosl GJ; Motzer RJ; Bajorin DF; Stasi JP; Sheinfeld J
J Clin Oncol; 2007 Dec; 25(35):5597-602. PubMed ID: 18065732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
